Archive

Volume 3, Number 2 / April issue 2017
Manuel Alberto M. Ferreira, José António Filipe, Manuel Coelho, José Chavaglia Neto
Nanotechnology applications in industry and medicine
Abstract

Since some time ago, nanotechnology has become one of the most promising scientific hopes in several human domains. Countless scientific studies in several areas of knowledge have been made since the nanoscale emergence, bringing their contribution to the nanoscience development. The recent researches in this field allowed the union of interests from several areas, such as physical sciences, molecular engineering, biology, biotechnology and medicine for example, contributing to the investigation of Biosystems at a nanoscale. Nanotechnology and nanobiosystems are becoming a privileged domain in order to reach an advanced level in the human development in many fields, as: a) the biotechnology processes; b) the synthesis of new drugs and their delivery on a live bod; c) the regenerative medicine and the new technologies in medicine: biotechnology and nanotechnology, body area networks for telemedicine-nanomedicine, nanoimaging, nanotechnological implants, in-body diagnostic systems, nanobiomedical wired devices, etc.; d) the application on the sustainability of the environment. Nanoscale can provide the tools to get better conditions to investigate Biosystems and to get advances with nanomaterials. These nanoscales, used in Biosystems, contribute to enhance very innovative and promising results in medical area. Improvements in the telemedicine and on health are expectable with new systems operations and new nanotechniques. Ethical, legal and social implications are posed and the need for discussing this theme shows the importance of nanotechnology to the society and the consequences, both positive and negative, that the development of nanotechnology will have to mankind in the future.
Keywords: Nanotechnology, nanomaterials, telemedicine, ethics

Cite this article:
Manuel Alberto M. Ferreira, José António Filipe, Manuel Coelho, José Chavaglia Neto. Nanotechnology applications in industry and medicine. Acta Scientiae et Intellectus, 3(2)2017, 31-50.


REFERENCES

  1. Ackerman, M., Craft, R., Ferrante, F., Kratz, M., Mandil, S. & Sapci, H. (2002). Telemedicine technology. State-of-the-art telemedicine/ telehealth symposium: An international perspective. Telemedicine Journal and e-health, 8 (1), 71–78.
  2. Allhoff, F. (2009). The coming era of nanomedicine. The American Journal of Bioethics, 9(10), 3-11.
  3. Allhoff, F. (2009). Response to open peer commentaries on “The coming era of nanomedicine”. The American Journal of Bioethics, 9(10): W1-W2.
  4. Bensaude-Vincent, B. (2010). Opening the Field of Nanoethics: Editorial Introduction to the Special Issue on Bionanoethics, II. HYLE – International Journal for Philosophy of Chemistry, Vol. 16, No. 1, 1-2.
  5. Capurro, R. (2006). Reflections on ethical aspects of nanomedicine. In http://www.capurro.de/nanoethics.html.
  6. Capurro, Rafael; Tamburrini, Guglielmo; Weber, Jutta (editors), Luca Botturi, Edoardo Datteri, Francesco Donnarumma, Mark Gasson, Satinder Gill, Alessandro Giordani, Cecilia Laschi, Federica Lucivero, Pericle Salvini, Matteo Santoro, Guglielmo Tamburrini, Jutta Weber, Kevin Warwick (authors), Deliverable D5 – Ethical issues in Brain Computer Interface Technologies. Ethicbots Consortium, c/o University “Federico II” of Naples (2005-2008), Ethicbots project - Emerging Technoethics of Human Interaction with Communication, Bionic, and robOTic systems Coordination Action - FP6 - Science and Society, in http://ethicbots.na.infn.it/restricted/doc/D5.pdf and http://ethicbots.na.infn.it/goals.php.
  7. Cattaneo, A.G., Gornati, R., Sabbioni, E., Chiriva-Internati, M., Cobos, E., Jenkins. M.R., & Bernardini, G. (2010). Nanotechnology and human health: Risks and benefits. Journal of Applied Toxicology 30(8), 730-744.
  8. Cavalcanti, A. (2009). Nanorobot Invention and Linux: The Open Technology Factor. An Open Letter to UNO General Secretary, Melbourne, Australia, in http://www.cannxs.org/open.pdf.
  9. Chavaglia, J. & Filipe, J.A. (unpublished draft), Nanotechnology and Processes: Nano-Photovoltaic panels as an innovation in energy market.
  10. Chavaglia, J., Filipe, J.A. (2011) “Photovoltaic solar energy contribution for Amazon’s companies” International Journal of Academic Research. Baku. Azerbaijan.Vol.3 (4), Part I, 225-231.
  11. Chavaglia, J., Filipe, J.A., Ferreira, M.A.M., Coelho, M. (2012). Nanotechnology and Processes: Nano-Photovoltaic Panels as an innovation in Energy Market. International Journal of Latest Trends in Finance and Economic Sciences 2(3), 197-205.
  12. Cruz-Cunha, M.M., Tavares, A. & Simoes, R. (2010). Handbook of research on developments in e-health and telemedicine: Technological and social perspectives. Hershey, PA: IGI Global.
  13. Euroresidentes (2011). Introdução à Nanotecnologia: O que é Nanotecnologia. Assessed in 26 de January 2011. Available in www.euroresidentes.com.
  14. Ferreira, M.A.M., Filipe, J.A., Chavaglia, J. (2014). Nanotechnology and Processes: The Nano-Photovoltaic Panels. Advanced Materials Research, 837, 694-698. DOI:10.4028/www.scientific.net/AMR.837.694.
  15. Filipe, J. A., Chavaglia, J., Ferreira, M. A. M. (2015). A Note on Nano-Photovoltaic Panels Emergence in Energy Market. International Journal of Latest Trends in Finance and Economic Sciences 5(1), 841-845.
  16. Filipe, J.A. (2015).Nanotechnology and Medicine Improvement. International Journal of Academic Research 7(2), 32-37. DOI: 10.7813/2075-4124.2015/7-2/A.5.
  17. Floridi, L. (1999). Philosophy and Computing: An Introduction. London - New York: Routledge, 1999.
  18. Floridi, L. (2007). A look into the Future Impact of ICT on Our Lives, The Information Society 23.1, 59-64, 2007.
  19. Floridi, L. (2008). Information Ethics, its Nature and Scope in Moral Philosophy and Information Technology, 40-65, edited by J. van den Hoven and J. Weckert. Cambridge: Cambridge University Press.
  20. Floridi, L. (2010). Information - A Very Short Introduction. Oxford: Oxford University Press.
  21. Floridi, L. (2011). The Philosophy of Information. Oxford: Oxford University Press.
  22. Freitas, R.A. (2005). What is nanomedicine?. Nanomedicine: Nanotechnology, Biology and Medicine Vol.1, Issue 1, 2-9.
  23. Freitas, R. A. (2007). Personal choice in the coming era of nanomedicine. In Patrick Lin et al. (Eds.), Nanoethics: The Ethical and Social Implications of Nanotechnology (pp. 161-172). New York, NY: John Wiley.
  24. Hristozov, D. & Malsch, I. (2009). Hazards and risks of engineered nanoparticles for the environment and human health. Sustainability, 1(4), 1161-1194.
  25. Jacobstein, N. (2006). Foresight Guidelines for Responsible Nanotechnology Development. Draft version. Foresight Institute. In http://www.foresight.org/guidelines/current.html#Intro.
  26. Lemos, R.T.S. & Kern, V.M. (2009). Technontologies, complexity, and hybrid interfaces. TripleC, 7, 29-37.
  27. Lindberg, S. (2005). Hans Jonas’s theory of Life in the face of Responsibility. Available on http://www.estig.ipbeja.pt/~ac_direito/ Lindberg_HansJonas.pdf
  28. Kubik, T., Bogunia-Kubik, K., & Sugisaka, M. (2005). Nanotechnology on Duty in Medical Applications. Current Pharmaceutical Biotechnology, 6, 17-33.
  29. Malsch, I. (Ed.) (2011). Nanotechnology and human health. Utrecht: CRC Press.
  30. Mcafee, A., & Brynjolfsson, E. (2008). Diferença competitiva. Havard Business Review.
  31. Mcdonough III, E.F., Zach, M.H., Lin, H.E., & Berdrow, I. (2009). Integrando a inovação e o conhecimento na estratégia. Revista Portuguesa e Brasileira de gestão.
  32. Mckibben, B., Rogers, J., & Nijhuis, M. (2009). National Geographic.
  33. Miyazaki, M. (2003). The Future of e-Health – Wired or not Wired. Business Briefing: Hospital Eng. & Facilities Manag. In http://www.touchbriefings.com/pdf/13/hosp031_r_miyazaki.PDF
  34. Mnyusiwalla, A., Daar A.S., & Singer P.A.(2003) ‘Mind the gap’: science and ethics in nanotechnology. Nanotechnology 14, R9–R13.
  35. Moghimi, S.M., Hunter, A.C., & Murray, J.C. (2005). Nanomedicine: current status and future prospects. The FASEB Journal.19, 311-330.
  36. Moore, R. (2007). Medical nanotechnology: Evolving appropriate risk tools. Medical Device Technology, 18(5), 36-37.
  37. Navrátil, V. (2008). Future development of nanotechnology and human health. In Contemporary Discourse on School and Health Investigation. Brno: University of Brno.
  38. Nogami, O., & Passos, C. R. (1999). Princípios de economia. São Paulo: Pioneira.
  39. Roco, M.C. (2003). Nanotechnology: convergence with modern biology and medicine. Current Opinion in Biotechnology, 14, 337–346.
  40. Rodotà, S. & Capurro R. (2005). Ethical aspects of ICT implants in the human body. Opinion of the European Group on Ethics in Science and New Technologies to the European Commission, nº 20, in http://ec.europa.eu/bepa/european-group-ethics/docs/avis20_en.pdf.
  41. Schumpeter, J.A. (1982). Teoria do desenvolvimento economico. São Paulo: Abril Cultural.
  42. Srivastava, D., & Atluri, S. A. (2002). Computational Nanotechnology: A Current Perspective. Computer Modeling in Engineering & Sciences (CMES), Tech Science Press, vol.3, no.5, 531-538.
  43. Wiener, N. (1948). Cybernetics - or Control and Communication in the Animal and the Machine. Cambridge, Mass.: The MIT Press, 11-12.
  44. Wiener, N. (1950). The Human Uses of Human Beings: Cybernetics and Society. Boston: Houghton Mifflin Co., 26-27.
  45. Yan, H., Zhang, X., Shen, Z., & Seeman, N.C. (2002). A robust DNA mechanical device controlled by hybridization topology. Nature 415, 62-65.